Lassina Zerbo said this week that having Iran and Israel ratify together would "certainly" lead to Egypt's ratification, and pave the way for a nuclear test-free zone in the West Asia.
The Comprehensive Nuclear Test Ban Treaty, known as the CTBT, has 196 member states of which 183 have signed the treaty and 164 have ratified it.
Also Read
Zerbo, speaking during a week-long conference marking the 20th anniversary of the treaty being opened for signing, said he doesn't expect immediate results on ratification, but is hoping to visit both Iran and Israel and talk to their leaders because "I think they're the ones who can unlock what is stopping the CTBT from moving."
In a briefing and an interview, he said that implementation of last summer's deal to rein in Iran's nuclear program and confirmation from Israeli and international scientists that Tehran can't produce nuclear weapons would mean "the biggest threat for Israel is gone and over."
Zerbo said the next step should then be to ratify the CTBT, which both Iran and Israel signed in 1996. He called this "a low-hanging fruit," toward the goal of nuclear nonproliferation and disarmament.
"Israel and Iran can make a huge difference for this treaty, and they have nothing to lose ... Absolutely nothing," Zerbo said. "Both of them can take leadership and show carte blanche to the world to say we have together decided to ratify the CTBT."
He said ratification by Iran and Israel would help defuse tensions between the countries, build trust, and provide momentum first for Egypt to ratify the CTBT and then to start negotiations for a nuclear test-free zone in the West Asia.
Zerbo said a nuclear test-free zone is an achievable step toward the much more difficult goal of establishing a nuclear-weapons-free-zone in the West Asia.
"You can't jump and get a weapon-free zone in the West Asia if the CTBT isn't ratified," he said. Arab nations have been calling for a nuclear-free zone since the mid-1990s but efforts to hold a conference to discuss the possibility have failed. One key issue has been differences with Israel, widely believed to have an arsenal of hundreds of nuclear weapons but has avoided confirming or denying their existence.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)